Better Therapeutics, Inc.

Better Therapeutics, Inc. is a prescription digital therapeutics company focused on cardiometabolic diseases that pursued a SPAC combination with Mountain Crest Acquisition Corp. II, which traded on Nasdaq under the ticker MCAD. The blank-check vehicle was sponsored by Mountain Crest Capital LLC and completed its IPO in 2021, targeting the healthcare and digital health sector. An 8-K filed September 1, 2021 marks a significant disclosure milestone in the de-SPAC process; following the completed business combination, Better Therapeutics traded under the ticker BTTX. The deal brought a clinically validated digital therapeutic pipeline into the public markets at a time of heightened investor interest in prescription digital health assets. Visit SpacDesk and sign up for full data, filings history, and deal analytics on this and hundreds of other SPAC transactions.